<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2017-05-10" version="213">
<accession>P11388</accession>
<accession>B2RTS1</accession>
<accession>Q71UN1</accession>
<accession>Q71UQ5</accession>
<accession>Q9HB24</accession>
<accession>Q9HB25</accession>
<accession>Q9HB26</accession>
<accession>Q9UP44</accession>
<accession>Q9UQP9</accession>
<name>TOP2A_HUMAN</name>
<protein>
<recommendedName>
<fullName>DNA topoisomerase 2-alpha</fullName>
<ecNumber>5.99.1.3</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DNA topoisomerase II, alpha isozyme</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TOP2A</name>
<name type="synonym">TOP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="7177" last="7181">
<title>Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.</title>
<authorList>
<person name="Tsai-Pflugfelder M."/>
<person name="Liu L.F."/>
<person name="Liu A.A."/>
<person name="Tewey K.M."/>
<person name="Whang-Peng J."/>
<person name="Knutsen T."/>
<person name="Huebner K."/>
<person name="Croce C.M."/>
<person name="Wang J.C."/>
</authorList>
<dbReference type="PubMed" id="2845399"/>
<dbReference type="DOI" id="10.1073/pnas.85.19.7177"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Cancer Res." volume="53" first="3591" last="3596">
<title>Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast.</title>
<authorList>
<person name="Wasserman R.A."/>
<person name="Austin C.A."/>
<person name="Fisher L.M."/>
<person name="Wang J.C."/>
</authorList>
<dbReference type="PubMed" id="8393377"/>
</citation>
<scope>SEQUENCE REVISION TO 109-114</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Gene" volume="221" first="255" last="266">
<title>Structural organization of the human TOP2A and TOP2B genes.</title>
<authorList>
<person name="Lang A.J."/>
<person name="Mirski S.E."/>
<person name="Cummings H.J."/>
<person name="Yu Q."/>
<person name="Gerlach J.H."/>
<person name="Cole S.P."/>
</authorList>
<dbReference type="PubMed" id="9795238"/>
<dbReference type="DOI" id="10.1016/S0378-1119(98)00468-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Biochim. Biophys. Acta" volume="1444" first="395" last="406">
<title>Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplication.</title>
<authorList>
<person name="Sng J.H."/>
<person name="Heaton V.J."/>
<person name="Bell M."/>
<person name="Mani P."/>
<person name="Austin C.A."/>
<person name="Fisher L.M."/>
</authorList>
<dbReference type="PubMed" id="10095062"/>
<dbReference type="DOI" id="10.1016/S0167-4781(99)00020-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="submission" date="2000-07" db="EMBL/GenBank/DDBJ databases">
<title>Two differentially spliced forms of topoisomerase II alpha and beta mRNAs are conserved between birds and humans.</title>
<authorList>
<person name="Petruti-Mot A.S."/>
<person name="Earnshaw W.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-500 (ISOFORMS 2; 3 AND 4)</scope>
</reference>
<reference key="9">
<citation type="submission" date="1998-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Neri S."/>
<person name="Govoni M."/>
<person name="Perrotta L."/>
<person name="Pozzi S."/>
<person name="Pession A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21 AND 48-72</scope>
</reference>
<reference key="10">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 1-17; 74-96; 124-131; 169-184; 243-251; 277-287; 325-336; 387-397; 467-478; 481-487; 500-519; 569-579; 702-713; 805-815; 828-835; 864-877; 937-958; 1021-1026 AND 1185-1196</scope>
<scope>ACETYLATION AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2009-03" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Waridel P."/>
<person name="Quadroni M."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 135-157; 228-241; 307-321; 325-336; 387-397; 401-416; 467-478; 536-550; 569-579; 640-655; 702-713; 805-815; 1011-1020; 1097-1114; 1169-1184; 1239-1259 AND 1374-1411</scope>
<scope>PHOSPHORYLATION AT SER-1106</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="34710" last="34718">
<title>Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469.</title>
<authorList>
<person name="Escargueil A.E."/>
<person name="Plisov S.Y."/>
<person name="Filhol O."/>
<person name="Cochet C."/>
<person name="Larsen A.K."/>
</authorList>
<dbReference type="PubMed" id="10942766"/>
<dbReference type="DOI" id="10.1074/jbc.M005179200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1469</scope>
<scope>MUTAGENESIS OF SER-1469</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="306" first="905" last="911">
<title>Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta.</title>
<authorList>
<person name="Mirski S.E."/>
<person name="Bielawski J.C."/>
<person name="Cole S.P."/>
</authorList>
<dbReference type="PubMed" id="12821127"/>
<dbReference type="DOI" id="10.1016/S0006-291X(03)01077-5"/>
</citation>
<scope>NUCLEAR EXPORT SIGNAL</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="31296" last="31303">
<title>Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.</title>
<authorList>
<person name="Yun J."/>
<person name="Tomida A."/>
<person name="Andoh T."/>
<person name="Tsuruo T."/>
</authorList>
<dbReference type="PubMed" id="15126503"/>
<dbReference type="DOI" id="10.1074/jbc.M401411200"/>
</citation>
<scope>INTERACTION WITH COPS5</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-1106; SER-1213; SER-1247; SER-1332; SER-1337; THR-1343; SER-1351; SER-1354; SER-1374; SER-1377 AND SER-1525</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1213; SER-1374; SER-1377 AND SER-1525</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1247</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Biochem. J." volume="411" first="27" last="32">
<title>Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.</title>
<authorList>
<person name="Iida M."/>
<person name="Matsuda M."/>
<person name="Komatani H."/>
</authorList>
<dbReference type="PubMed" id="18062778"/>
<dbReference type="DOI" id="10.1042/BJ20071394"/>
</citation>
<scope>PHOSPHORYLATION AT THR-1343</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1504</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-1213; SER-1247; SER-1332; SER-1337 AND SER-1377</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Nucleic Acids Res." volume="36" first="5822" last="5831">
<title>The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation.</title>
<authorList>
<person name="Williamson E.A."/>
<person name="Rasila K.K."/>
<person name="Corwin L.K."/>
<person name="Wray J."/>
<person name="Beck B.D."/>
<person name="Severns V."/>
<person name="Mobarak C."/>
<person name="Lee S.H."/>
<person name="Nickoloff J.A."/>
<person name="Hromas R."/>
</authorList>
<dbReference type="PubMed" id="18790802"/>
<dbReference type="DOI" id="10.1093/nar/gkn560"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SETMAR</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1106; SER-1213; SER-1332; SER-1337; THR-1343; SER-1351; SER-1392; SER-1393; SER-1449; SER-1469; THR-1470; SER-1471; SER-1474 AND SER-1525</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="1862" last="1869">
<title>Use of divalent metal ions in the DNA cleavage reaction of human type II topoisomerases.</title>
<authorList>
<person name="Deweese J.E."/>
<person name="Burch A.M."/>
<person name="Burgin A.B."/>
<person name="Osheroff N."/>
</authorList>
<dbReference type="PubMed" id="19222228"/>
<dbReference type="DOI" id="10.1021/bi8023256"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="8940" last="8947">
<title>Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.</title>
<authorList>
<person name="Deweese J.E."/>
<person name="Guengerich F.P."/>
<person name="Burgin A.B."/>
<person name="Osheroff N."/>
</authorList>
<dbReference type="PubMed" id="19697956"/>
<dbReference type="DOI" id="10.1021/bi900875c"/>
</citation>
<scope>MUTAGENESIS OF GLU-461; ASP-541; ASP-543 AND ASP-545</scope>
<scope>PUTATIVE METAL-BINDING SITES</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="382" last="392">
<title>Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.</title>
<authorList>
<person name="Grozav A.G."/>
<person name="Chikamori K."/>
<person name="Kozuki T."/>
<person name="Grabowski D.R."/>
<person name="Bukowski R.M."/>
<person name="Willard B."/>
<person name="Kinter M."/>
<person name="Andersen A.H."/>
<person name="Ganapathi R."/>
<person name="Ganapathi M.K."/>
</authorList>
<dbReference type="PubMed" id="19043076"/>
<dbReference type="DOI" id="10.1093/nar/gkn934"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1106 BY CSNK1D/CK1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1247; SER-1374; SER-1387; SER-1393; SER-1504 AND SER-1525</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="5681" last="5691">
<title>Metnase promotes restart and repair of stalled and collapsed replication forks.</title>
<authorList>
<person name="De Haro L.P."/>
<person name="Wray J."/>
<person name="Williamson E.A."/>
<person name="Durant S.T."/>
<person name="Corwin L."/>
<person name="Gentry A.C."/>
<person name="Osheroff N."/>
<person name="Lee S.H."/>
<person name="Hromas R."/>
<person name="Nickoloff J.A."/>
</authorList>
<dbReference type="PubMed" id="20457750"/>
<dbReference type="DOI" id="10.1093/nar/gkq339"/>
</citation>
<scope>INTERACTION WITH SETMAR</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; THR-282; SER-1106; THR-1205; SER-1213; SER-1247; SER-1332; SER-1337; THR-1343; SER-1351; SER-1354; SER-1374; SER-1377; SER-1471; SER-1474; SER-1495; SER-1504 AND SER-1525</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-1106; SER-1213; SER-1247; SER-1295; SER-1297; SER-1299; SER-1302; SER-1332; SER-1337; THR-1343; SER-1351; SER-1354; SER-1374; SER-1377; SER-1469; THR-1470; SER-1471; SER-1474; SER-1476 AND SER-1525</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="1147" last="1154">
<title>Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity.</title>
<authorList>
<person name="Schmidt B.H."/>
<person name="Osheroff N."/>
<person name="Berger J.M."/>
</authorList>
<dbReference type="PubMed" id="23022727"/>
<dbReference type="DOI" id="10.1038/nsmb.2388"/>
</citation>
<scope>MUTAGENESIS OF 342-LYS--LYS-344</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="Nucleic Acids Res." volume="40" first="1621" last="1635">
<title>RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression.</title>
<authorList>
<person name="Ramamoorthy M."/>
<person name="Tadokoro T."/>
<person name="Rybanska I."/>
<person name="Ghosh A.K."/>
<person name="Wersto R."/>
<person name="May A."/>
<person name="Kulikowicz T."/>
<person name="Sykora P."/>
<person name="Croteau D.L."/>
<person name="Bohr V.A."/>
</authorList>
<dbReference type="PubMed" id="22013166"/>
<dbReference type="DOI" id="10.1093/nar/gkr844"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH RECQL5</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="2925" last="2930">
<title>DNA cleavage and opening reactions of human topoisomerase IIalpha are regulated via Mg2+-mediated dynamic bending of gate-DNA.</title>
<authorList>
<person name="Lee S."/>
<person name="Jung S.R."/>
<person name="Heo K."/>
<person name="Byl J.A."/>
<person name="Deweese J.E."/>
<person name="Osheroff N."/>
<person name="Hohng S."/>
</authorList>
<dbReference type="PubMed" id="22323612"/>
<dbReference type="DOI" id="10.1073/pnas.1115704109"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLU-461; ASP-541 AND ASP-543</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-1106; SER-1213; THR-1244; SER-1247; SER-1374; SER-1377; SER-1391; SER-1449; SER-1469; SER-1471; SER-1474; SER-1495 AND SER-1504</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1228; LYS-1240; LYS-1385 AND LYS-1492</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1240</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-639; LYS-662; LYS-676; LYS-1075; LYS-1196; LYS-1228; LYS-1240; LYS-1385 AND LYS-1442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1228 AND LYS-1240</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37041" last="37047">
<title>Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase.</title>
<authorList>
<person name="Wei H."/>
<person name="Ruthenburg A.J."/>
<person name="Bechis S.K."/>
<person name="Verdine G.L."/>
</authorList>
<dbReference type="PubMed" id="16100112"/>
<dbReference type="DOI" id="10.1074/jbc.M506520200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) OF 29-428 IN COMPLEX WITH ADP</scope>
<scope>X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) OF 29-428 IN COMPLEX WITH AMPPNP</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Mol. Biol." volume="424" first="109" last="124">
<title>The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.</title>
<authorList>
<person name="Wendorff T.J."/>
<person name="Schmidt B.H."/>
<person name="Heslop P."/>
<person name="Austin C.A."/>
<person name="Berger J.M."/>
</authorList>
<dbReference type="PubMed" id="22841979"/>
<dbReference type="DOI" id="10.1016/j.jmb.2012.07.014"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 431-1193 IN COMPLEX WITH DNA AND MAGNESIUM ION</scope>
<scope>SUBUNIT</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E107289" last="E107289">
<title>Structure of the N-terminal Gyrase B fragment in complex with ADPPi reveals rigid-body motion induced by ATP hydrolysis.</title>
<authorList>
<person name="Stanger F.V."/>
<person name="Dehio C."/>
<person name="Schirmer T."/>
</authorList>
<dbReference type="PubMed" id="25202966"/>
<dbReference type="DOI" id="10.1371/journal.pone.0107289"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 29-428 IN COMPLEX WITH ADP AND ATP ANALOGS</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1991" name="Cancer Res." volume="51" first="4729" last="4731">
<title>Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.</title>
<authorList>
<person name="Hinds M."/>
<person name="Deisseroth K."/>
<person name="Mayes J."/>
<person name="Altschuler E."/>
<person name="Jansen R."/>
<person name="Ledley F.D."/>
<person name="Zwelling L.A."/>
</authorList>
<dbReference type="PubMed" id="1651812"/>
</citation>
<scope>VARIANT AMSACRINE-RESISTANT LYS-487</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="7654" last="7658">
<title>Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.</title>
<authorList>
<person name="Bugg B.Y."/>
<person name="Danks M.K."/>
<person name="Beck W.T."/>
<person name="Suttle D.P."/>
</authorList>
<dbReference type="PubMed" id="1652758"/>
<dbReference type="DOI" id="10.1073/pnas.88.17.7654"/>
</citation>
<scope>VARIANT TENIPOSIDE-RESISTANT GLN-450</scope>
</reference>
<comment type="function">
<text evidence="22 30 35 36">Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks. Essential during mitosis and meiosis for proper segregation of daughter chromosomes. May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="23 32 33">ATP-dependent breakage, passage and rejoining of double-stranded DNA.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="44 45 46 47">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<cofactor evidence="44 45 46 47">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
<cofactor evidence="44 45 46 47">
<name>Ca(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29108"/>
</cofactor>
<text evidence="44 45 46 47">Binds two Mg(2+) per subunit. The magnesium ions form salt bridges with both the protein and the DNA. Can also accept other divalent metal cations, such as Mn(2+) or Ca(2+).</text>
</comment>
<comment type="enzyme regulation">
<text>Specifically inhibited by the intercalating agent amsacrine.</text>
</comment>
<comment type="subunit">
<text evidence="25 26 34 35 37">Homodimer. Interacts with COPS5. Interacts with RECQL5; this stimulates DNA decatenation. Interacts with SETMAR; stimulates the topoisomerase activity (PubMed:18790802, PubMed:20457750).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-539628"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-539628"/>
<interactant intactId="EBI-704279">
<id>Q05655</id>
<label>PRKCD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="35">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Nucleus</location>
<location evidence="35">Nucleoplasm</location>
</subcellularLocation>
<text>Generally located in the nucleoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P11388-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P11388-2</id>
<name>2</name>
<sequence type="described" ref="VSP_006531"/>
</isoform>
<isoform>
<id>P11388-3</id>
<name>3</name>
<sequence type="described" ref="VSP_006529"/>
</isoform>
<isoform>
<id>P11388-4</id>
<name>4</name>
<sequence type="described" ref="VSP_006530"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="21 39">The N-terminus has several structural domains; the ATPase domain (about residues 1-265), the transducer domain (about 266-428) and the toprim domain (455-572) (PubMed:25202966). Comparing different structures shows ATP hydrolysis induces domain shifts in the N-terminus that are probably part of the mechanism of DNA cleavage and rejoining (PubMed:25202966).</text>
</comment>
<comment type="PTM">
<text evidence="24 29 31 41">Phosphorylation has no effect on catalytic activity. However, phosphorylation at Ser-1106 by CSNK1D/CK1 promotes DNA cleavable complex formation.</text>
</comment>
<comment type="miscellaneous">
<text>Eukaryotic topoisomerase I and II can relax both negative and positive supercoils, whereas prokaryotic enzymes relax only negative supercoils.</text>
</comment>
<comment type="similarity">
<text evidence="43">Belongs to the type II topoisomerase family.</text>
</comment>
<dbReference type="EC" id="5.99.1.3"/>
<dbReference type="EMBL" id="J04088">
<property type="protein sequence ID" value="AAA61209.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071747">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071738">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071739">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071740">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071741">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071742">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071743">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071744">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071745">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF071746">
<property type="protein sequence ID" value="AAC77388.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011741">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011742">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011743">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011744">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011745">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011746">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011747">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011748">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011749">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011750">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011751">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011752">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011753">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011754">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011755">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011756">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011757">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ011758">
<property type="protein sequence ID" value="CAA09762.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC080112">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF285157">
<property type="protein sequence ID" value="AAG13403.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF285158">
<property type="protein sequence ID" value="AAG13404.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471152">
<property type="protein sequence ID" value="EAW60663.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC140791">
<property type="protein sequence ID" value="AAI40792.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF285159">
<property type="protein sequence ID" value="AAG13405.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF069522">
<property type="protein sequence ID" value="AAC23518.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF064590">
<property type="protein sequence ID" value="AAC16736.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45672.1">
<molecule id="P11388-1"/>
</dbReference>
<dbReference type="PIR" id="A40493">
<property type="entry name" value="A40493"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001058.2">
<molecule id="P11388-1"/>
<property type="nucleotide sequence ID" value="NM_001067.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.156346"/>
<dbReference type="PDB" id="1LWZ">
<property type="method" value="Model"/>
<property type="chains" value="A=431-1200"/>
</dbReference>
<dbReference type="PDB" id="1ZXM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A/B=29-428"/>
</dbReference>
<dbReference type="PDB" id="1ZXN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A/B/C/D=29-428"/>
</dbReference>
<dbReference type="PDB" id="4FM9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=431-1193"/>
</dbReference>
<dbReference type="PDB" id="4R1F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A/B/C/D=29-428"/>
</dbReference>
<dbReference type="PDBsum" id="1LWZ"/>
<dbReference type="PDBsum" id="1ZXM"/>
<dbReference type="PDBsum" id="1ZXN"/>
<dbReference type="PDBsum" id="4FM9"/>
<dbReference type="PDBsum" id="4R1F"/>
<dbReference type="ProteinModelPortal" id="P11388"/>
<dbReference type="SMR" id="P11388"/>
<dbReference type="BioGrid" id="113006">
<property type="interactions" value="100"/>
</dbReference>
<dbReference type="DIP" id="DIP-33887N"/>
<dbReference type="IntAct" id="P11388">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="MINT" id="MINT-98770"/>
<dbReference type="STRING" id="9606.ENSP00000411532"/>
<dbReference type="BindingDB" id="P11388"/>
<dbReference type="ChEMBL" id="CHEMBL1806"/>
<dbReference type="DrugBank" id="DB05022">
<property type="generic name" value="Amonafide"/>
</dbReference>
<dbReference type="DrugBank" id="DB06263">
<property type="generic name" value="Amrubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00276">
<property type="generic name" value="Amsacrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04975">
<property type="generic name" value="Banoxantrone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00537">
<property type="generic name" value="Ciprofloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00970">
<property type="generic name" value="Dactinomycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00694">
<property type="generic name" value="Daunorubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00380">
<property type="generic name" value="Dexrazoxane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00997">
<property type="generic name" value="Doxorubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05129">
<property type="generic name" value="Elsamitrucin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00467">
<property type="generic name" value="Enoxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00445">
<property type="generic name" value="Epirubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00773">
<property type="generic name" value="Etoposide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09047">
<property type="generic name" value="Finafloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04576">
<property type="generic name" value="Fleroxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01645">
<property type="generic name" value="Genistein"/>
</dbReference>
<dbReference type="DrugBank" id="DB01177">
<property type="generic name" value="Idarubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01137">
<property type="generic name" value="Levofloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00978">
<property type="generic name" value="Lomefloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04967">
<property type="generic name" value="Lucanthone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01204">
<property type="generic name" value="Mitoxantrone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00218">
<property type="generic name" value="Moxifloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01059">
<property type="generic name" value="Norfloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01165">
<property type="generic name" value="Ofloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00487">
<property type="generic name" value="Pefloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01179">
<property type="generic name" value="Podofilox"/>
</dbReference>
<dbReference type="DrugBank" id="DB05920">
<property type="generic name" value="RTA 744"/>
</dbReference>
<dbReference type="DrugBank" id="DB04978">
<property type="generic name" value="SP1049C"/>
</dbReference>
<dbReference type="DrugBank" id="DB01208">
<property type="generic name" value="Sparfloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00444">
<property type="generic name" value="Teniposide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00685">
<property type="generic name" value="Trovafloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00385">
<property type="generic name" value="Valrubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB06042">
<property type="generic name" value="ZEN-012"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2637"/>
<dbReference type="iPTMnet" id="P11388"/>
<dbReference type="PhosphoSitePlus" id="P11388"/>
<dbReference type="SwissPalm" id="P11388"/>
<dbReference type="BioMuta" id="TOP2A"/>
<dbReference type="DMDM" id="13959709"/>
<dbReference type="UCD-2DPAGE" id="P11388"/>
<dbReference type="EPD" id="P11388"/>
<dbReference type="MaxQB" id="P11388"/>
<dbReference type="PaxDb" id="P11388"/>
<dbReference type="PeptideAtlas" id="P11388"/>
<dbReference type="PRIDE" id="P11388"/>
<dbReference type="Ensembl" id="ENST00000423485">
<molecule id="P11388-1"/>
<property type="protein sequence ID" value="ENSP00000411532"/>
<property type="gene ID" value="ENSG00000131747"/>
</dbReference>
<dbReference type="GeneID" id="7153"/>
<dbReference type="KEGG" id="hsa:7153"/>
<dbReference type="UCSC" id="uc002huq.4">
<molecule id="P11388-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7153"/>
<dbReference type="DisGeNET" id="7153"/>
<dbReference type="GeneCards" id="TOP2A"/>
<dbReference type="H-InvDB" id="HIX0013797"/>
<dbReference type="HGNC" id="HGNC:11989">
<property type="gene designation" value="TOP2A"/>
</dbReference>
<dbReference type="HPA" id="CAB002448"/>
<dbReference type="HPA" id="HPA006458"/>
<dbReference type="HPA" id="HPA026773"/>
<dbReference type="MalaCards" id="TOP2A"/>
<dbReference type="MIM" id="126430">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P11388"/>
<dbReference type="OpenTargets" id="ENSG00000131747"/>
<dbReference type="Orphanet" id="635">
<property type="disease" value="Neuroblastoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA354"/>
<dbReference type="eggNOG" id="KOG0355">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0187">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="eggNOG" id="COG0188">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000016222"/>
<dbReference type="HOVERGEN" id="HBG052998"/>
<dbReference type="InParanoid" id="P11388"/>
<dbReference type="KO" id="K03164"/>
<dbReference type="OMA" id="VKFIVKM"/>
<dbReference type="OrthoDB" id="EOG091G00U2"/>
<dbReference type="PhylomeDB" id="P11388"/>
<dbReference type="TreeFam" id="TF105282"/>
<dbReference type="BRENDA" id="5.99.1.3">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1538133">
<property type="pathway name" value="G0 and Early G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4615885">
<property type="pathway name" value="SUMOylation of DNA replication proteins"/>
</dbReference>
<dbReference type="SignaLink" id="P11388"/>
<dbReference type="SIGNOR" id="P11388"/>
<dbReference type="EvolutionaryTrace" id="P11388"/>
<dbReference type="GeneWiki" id="TOP2A"/>
<dbReference type="GenomeRNAi" id="7153"/>
<dbReference type="PRO" id="PR:P11388"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000131747"/>
<dbReference type="CleanEx" id="HS_TOP2A"/>
<dbReference type="ExpressionAtlas" id="P11388">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P11388">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000793">
<property type="term" value="C:condensed chromosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009330">
<property type="term" value="C:DNA topoisomerase complex (ATP-hydrolyzing)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008301">
<property type="term" value="F:DNA binding, bending"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003918">
<property type="term" value="F:DNA topoisomerase type II (ATP-hydrolyzing) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008094">
<property type="term" value="F:DNA-dependent ATPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008144">
<property type="term" value="F:drug binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043130">
<property type="term" value="F:ubiquitin binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030263">
<property type="term" value="P:apoptotic chromosome condensation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006266">
<property type="term" value="P:DNA ligation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006265">
<property type="term" value="P:DNA topological change"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040016">
<property type="term" value="P:embryonic cleavage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002244">
<property type="term" value="P:hematopoietic progenitor cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044774">
<property type="term" value="P:mitotic DNA integrity checkpoint"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006312">
<property type="term" value="P:mitotic recombination"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045870">
<property type="term" value="P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045070">
<property type="term" value="P:positive regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000712">
<property type="term" value="P:resolution of meiotic recombination intermediates"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000819">
<property type="term" value="P:sister chromatid segregation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd03365">
<property type="entry name" value="TOPRIM_TopoIIA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.268.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.1360.40">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.230.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.670">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.199.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR024946">
<property type="entry name" value="Arg_repress_C-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR012542">
<property type="entry name" value="DTHCT"/>
</dbReference>
<dbReference type="InterPro" id="IPR003594">
<property type="entry name" value="HATPase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR020568">
<property type="entry name" value="Ribosomal_S5_D2-typ_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014721">
<property type="entry name" value="Ribosomal_S5_D2-typ_fold_subgr"/>
</dbReference>
<dbReference type="InterPro" id="IPR001241">
<property type="entry name" value="Topo_IIA"/>
</dbReference>
<dbReference type="InterPro" id="IPR013760">
<property type="entry name" value="Topo_IIA-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002205">
<property type="entry name" value="Topo_IIA_A/C"/>
</dbReference>
<dbReference type="InterPro" id="IPR013758">
<property type="entry name" value="Topo_IIA_A/C_ab"/>
</dbReference>
<dbReference type="InterPro" id="IPR013757">
<property type="entry name" value="Topo_IIA_A_a"/>
</dbReference>
<dbReference type="InterPro" id="IPR013506">
<property type="entry name" value="Topo_IIA_bsu_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013759">
<property type="entry name" value="Topo_IIA_cen_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018522">
<property type="entry name" value="TopoIIA_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR031660">
<property type="entry name" value="TOPRIM_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR006171">
<property type="entry name" value="TOPRIM_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR034157">
<property type="entry name" value="TOPRIM_TopoII"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10169">
<property type="entry name" value="PTHR10169"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00204">
<property type="entry name" value="DNA_gyraseB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00521">
<property type="entry name" value="DNA_topoisoIV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08070">
<property type="entry name" value="DTHCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02518">
<property type="entry name" value="HATPase_c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01751">
<property type="entry name" value="Toprim"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16898">
<property type="entry name" value="TOPRIM_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00418">
<property type="entry name" value="TPI2FAMILY"/>
</dbReference>
<dbReference type="SMART" id="SM00433">
<property type="entry name" value="TOP2c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00434">
<property type="entry name" value="TOP4c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54211">
<property type="entry name" value="SSF54211"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55874">
<property type="entry name" value="SSF55874"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56719">
<property type="entry name" value="SSF56719"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00177">
<property type="entry name" value="TOPOISOMERASE_II"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50880">
<property type="entry name" value="TOPRIM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0413">Isomerase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0799">Topoisomerase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="DNA topoisomerase 2-alpha" id="PRO_0000145363">
<location>
<begin position="1"/>
<end position="1531"/>
</location>
</feature>
<feature type="domain" description="Toprim" evidence="23">
<location>
<begin position="455"/>
<end position="572"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="26 39">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="26 39">
<location>
<begin position="161"/>
<end position="168"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="26 49">
<location>
<begin position="376"/>
<end position="378"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA" evidence="48">
<location>
<begin position="342"/>
<end position="344"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA" evidence="37">
<location>
<begin position="990"/>
<end position="999"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal">
<location>
<begin position="1018"/>
<end position="1028"/>
</location>
</feature>
<feature type="active site" description="O-(5'-phospho-DNA)-tyrosine intermediate" evidence="20">
<location>
<position position="805"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1; catalytic" evidence="23">
<location>
<position position="461"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1; catalytic" evidence="23">
<location>
<position position="541"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="37">
<location>
<position position="541"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="37">
<location>
<position position="543"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="26 39">
<location>
<position position="91"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="26 39">
<location>
<position position="120"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="23">
<location>
<position position="489"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="492"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="661"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="662"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="723"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="757"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="763"/>
</location>
</feature>
<feature type="site" description="Transition state stabilizer" evidence="19">
<location>
<position position="804"/>
</location>
</feature>
<feature type="site" description="Important for DNA bending; intercalates between base pairs of target DNA" evidence="19">
<location>
<position position="856"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA" evidence="37">
<location>
<position position="931"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="11 12 13 40">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 9 11 12 14">
<location>
<position position="4"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="282"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1" evidence="5 8 11 12 14 31 41">
<location>
<position position="1106"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="1205"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 8 9 11 12 14">
<location>
<position position="1213"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="1244"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 9 10 11 12 14">
<location>
<position position="1247"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="1295"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="1297"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="1299"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="1302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="1327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 9 11 12">
<location>
<position position="1332"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 9 11 12">
<location>
<position position="1337"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PLK3" evidence="5 8 11 12 29">
<location>
<position position="1343"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 11 12">
<location>
<position position="1351"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11 12">
<location>
<position position="1354"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 10 11 12 14">
<location>
<position position="1374"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 9 11 12 14">
<location>
<position position="1377"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1391"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1392"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 10">
<location>
<position position="1393"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="22">
<location>
<position position="1422"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="22">
<location>
<position position="1442"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 14">
<location>
<position position="1449"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="8 12 14 24">
<location>
<position position="1469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 12">
<location>
<position position="1470"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 12 14">
<location>
<position position="1471"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 12 14">
<location>
<position position="1474"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="1476"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 14">
<location>
<position position="1495"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 11 14">
<location>
<position position="1504"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 8 10 11 12">
<location>
<position position="1525"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="639"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="662"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="676"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="1075"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="1196"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17 18">
<location>
<position position="1228"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="15">
<location>
<position position="1240"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 16 17 18">
<location>
<position position="1240"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 18">
<location>
<position position="1385"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="18">
<location>
<position position="1442"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="1492"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_006529" evidence="42">
<original>K</original>
<variation>KSSKYWSSRKSKQHILLNFFVLFKFINDAFFGICPFK</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_006530" evidence="42">
<original>Q</original>
<variation>QRELCNGAILAHCNLRLMGSSDSPASASRVAGIAGGCHHTQLIFVFLVETGFHHVGQAGLERLTSGDPPASASQSSGITDVK</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_006531" evidence="42">
<original>A</original>
<variation>AHLYSRFLIDPFFPNMIPNMIFSFSKA</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence variant" description="In teniposide (VM-26) resistant cells; dbSNP:rs746765101." id="VAR_007532" evidence="28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In amsacrine resistant cells; dbSNP:rs267607133." id="VAR_007533" evidence="27">
<original>R</original>
<variation>K</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28969502." id="VAR_029245">
<original>T</original>
<variation>K</variation>
<location>
<position position="1324"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34300454." id="VAR_052594">
<original>G</original>
<variation>D</variation>
<location>
<position position="1386"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11540720." id="VAR_052595">
<original>A</original>
<variation>S</variation>
<location>
<position position="1515"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced enzyme activity; abolishes stimulation of ATPase activity upon DNA binding." evidence="38">
<original>KKK</original>
<variation>AAA</variation>
<location>
<begin position="342"/>
<end position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity; abolishes stimulation of ATPase activity upon DNA binding." evidence="38">
<original>KKK</original>
<variation>EEE</variation>
<location>
<begin position="342"/>
<end position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs bending of target DNA. Strongly reduced DNA cleavage." evidence="33 36">
<original>E</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs bending of target DNA. Strongly reduced DNA cleavage." evidence="33 36">
<original>D</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs bending of target DNA. Strongly reduced DNA cleavage." evidence="33 36">
<original>D</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="543"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced DNA cleavage." evidence="33">
<original>D</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="545"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to the antibody MPM2." evidence="24">
<original>S</original>
<variation>A</variation>
<location>
<position position="1469"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA09762." ref="4" evidence="43">
<original>D</original>
<variation>H</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA09762." ref="4" evidence="43">
<original>E</original>
<variation>Q</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA09762." ref="4" evidence="43">
<original>D</original>
<variation>H</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA09762." ref="4" evidence="43">
<original>F</original>
<variation>L</variation>
<location>
<position position="1022"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA09762." ref="4" evidence="43">
<original>T</original>
<variation>S</variation>
<location>
<position position="1274"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA61209." ref="1" evidence="43">
<original>S</original>
<variation>P</variation>
<location>
<position position="1295"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="30"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="39"/>
<end position="45"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="48"/>
<end position="51"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="57"/>
<end position="65"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="69"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="79"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="104"/>
<end position="110"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="111"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="128"/>
<end position="130"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="131"/>
<end position="134"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="137"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="144"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="153"/>
<end position="155"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="166"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="174"/>
<end position="183"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="184"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="188"/>
<end position="195"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="214"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="223"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="233"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="254"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="281"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="289"/>
<end position="294"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="297"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="305"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="309"/>
<end position="314"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="324"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="346"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="353"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="360"/>
<end position="366"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="373"/>
<end position="375"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="385"/>
<end position="387"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="388"/>
<end position="390"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="396"/>
<end position="402"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="407"/>
<end position="410"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="411"/>
<end position="415"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="423"/>
<end position="425"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="445"/>
<end position="448"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="452"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="456"/>
<end position="462"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="463"/>
<end position="476"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="478"/>
<end position="486"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="498"/>
<end position="503"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="505"/>
<end position="514"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="525"/>
<end position="530"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="534"/>
<end position="539"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="544"/>
<end position="560"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="562"/>
<end position="566"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="570"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="577"/>
<end position="581"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="586"/>
<end position="590"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="592"/>
<end position="601"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="607"/>
<end position="612"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="616"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="621"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="631"/>
<end position="634"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="635"/>
<end position="639"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="644"/>
<end position="653"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="658"/>
<end position="678"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="685"/>
<end position="688"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="691"/>
<end position="694"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="695"/>
<end position="701"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="703"/>
<end position="714"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="718"/>
<end position="720"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="724"/>
<end position="735"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="744"/>
<end position="754"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="762"/>
<end position="772"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="793"/>
<end position="799"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="803"/>
<end position="805"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="812"/>
<end position="817"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="822"/>
<end position="824"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="831"/>
<end position="833"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="848"/>
<end position="850"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="853"/>
<end position="856"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="861"/>
<end position="864"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="869"/>
<end position="881"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="897"/>
<end position="903"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="906"/>
<end position="910"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="921"/>
<end position="923"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="932"/>
<end position="938"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="940"/>
<end position="944"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="948"/>
<end position="950"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="955"/>
<end position="959"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="968"/>
<end position="971"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="974"/>
<end position="983"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="985"/>
<end position="988"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="992"/>
<end position="996"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1000"/>
<end position="1003"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1009"/>
<end position="1011"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1015"/>
<end position="1059"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1070"/>
<end position="1080"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1086"/>
<end position="1091"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1126"/>
<end position="1129"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1138"/>
<end position="1160"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1163"/>
<end position="1189"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZXM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZXN"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4FM9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000250"/>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P06786"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P0AES6"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01320"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00995"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10942766"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15126503"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16100112"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1651812"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1652758"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18062778"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18790802"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19043076"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19222228"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19697956"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20457750"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22013166"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22323612"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22841979"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23022727"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25202966"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="41" type="ECO:0000269">
<source ref="11"/>
</evidence>
<evidence key="42" type="ECO:0000303">
<source ref="8"/>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<evidence key="44" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19222228"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19697956"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22323612"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22841979"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23022727"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25202966"/>
</source>
</evidence>
<sequence length="1531" mass="174385" checksum="3DF40BC9E84789DC" modified="2001-05-04" version="3">
MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTYIGSVELVTQQ
MWVYDEDVGINYREVTFVPGLYKIFDEILVNAADNKQRDPKMSCIRVTIDPENNLISIWN
NGKGIPVVEHKVEKMYVPALIFGQLLTSSNYDDDEKKVTGGRNGYGAKLCNIFSTKFTVE
TASREYKKMFKQTWMDNMGRAGEMELKPFNGEDYTCITFQPDLSKFKMQSLDKDIVALMV
RRAYDIAGSTKDVKVFLNGNKLPVKGFRSYVDMYLKDKLDETGNSLKVIHEQVNHRWEVC
LTMSEKGFQQISFVNSIATSKGGRHVDYVADQIVTKLVDVVKKKNKGGVAVKAHQVKNHM
WIFVNALIENPTFDSQTKENMTLQPKSFGSTCQLSEKFIKAAIGCGIVESILNWVKFKAQ
VQLNKKCSAVKHNRIKGIPKLDDANDAGGRNSTECTLILTEGDSAKTLAVSGLGVVGRDK
YGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKNYEDEDSLKTLRYGKIMIMT
DQDQDGSHIKGLLINFIHHNWPSLLRHRFLEEFITPIVKVSKNKQEMAFYSLPEFEEWKS
STPNHKKWKVKYYKGLGTSTSKEAKEYFADMKRHRIQFKYSGPEDDAAISLAFSKKQIDD
RKEWLTNFMEDRRQRKLLGLPEDYLYGQTTTYLTYNDFINKELILFSNSDNERSIPSMVD
GLKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSSYHHGEMSLMMTIINLAQNFVGSNN
LNLLQPIGQFGTRLHGGKDSASPRYIFTMLSSLARLLFPPKDDHTLKFLYDDNQRVEPEW
YIPIIPMVLINGAEGIGTGWSCKIPNFDVREIVNNIRRLMDGEEPLPMLPSYKNFKGTIE
ELAPNQYVISGEVAILNSTTIEISELPVRTWTQTYKEQVLEPMLNGTEKTPPLITDYREY
HTDTTVKFVVKMTEEKLAEAERVGLHKVFKLQTSLTCNSMVLFDHVGCLKKYDTVLDILR
DFFELRLKYYGLRKEWLLGMLGAESAKLNNQARFILEKIDGKIIIENKPKKELIKVLIQR
GYDSDPVKAWKEAQQKVPDEEENEESDNEKETEKSDSVTDSGPTFNYLLDMPLWYLTKEK
KDELCRLRNEKEQELDTLKRKSPSDLWKEDLATFIEELEAVEAKEKQDEQVGLPGKGGKA
KGKKTQMAEVLPSPRGQRVIPRITIEMKAEAEKKNKKKIKNENTEGSPQEDGVELEGLKQ
RLEKKQKREPGTKTKKQTTLAFKPIKKGKKRNPWSDSESDRSSDESNFDVPPRETEPRRA
ATKTKFTMDLDSDEDFSDFDEKTDDEDFVPSDASPPKTKTSPKLSNKELKPQKSVVSDLE
ADDVKGSVPLSSSPPATHFPDETEITNPVPKKNVTVKKTAAKSQSSTSTTGAKKRAAPKG
TKRDPALNSGVSQKPDPAKTKNRRKRKPSTSDDSDSNFEKIVSKAVTSKKSKGESDDFHM
DFDSAVAPRAKSVRAKKPIKYLEESDEDDLF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>